1 McCay PB., "Vitamin E: interactions with free radicals and ascorbate" 5 : 323-340, 1985
2 Jang AS, "The relationship between alveolar epithelial proliferation and airway obstruction after ozone exposure" 57 : 737-740, 2002
3 문희범, "The Role of Oxidative Stress in the Pathogenesis of Asthma" 대한천식알레르기학회 2 (2): 183-187, 2010
4 De Azevedo WF Jr, "Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase" 93 : 2735-2740, 1996
5 Saliou C, "Solar ultravioletinduced erythema in human skin and nuclear factorkappa- B-dependent gene expression in keratinocytes are modulated by a French maritime pine bark extract" 30 : 154-160, 2001
6 Finkel T., "Signal transduction by reactive oxygen species" 194 : 7-15, 2011
7 Morabia A, "Serum retinol and airway obstruction" 132 : 77-82, 1990
8 Boege F, "Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase" 271 : 2262-2270, 1996
9 Comhair SA, "Redox control of asthma: molecular mechanisms and therapeutic opportunities" 12 : 93-124, 2010
10 Rohdewald P., "Pycnogenol, In Flavonoids in Health and Disease" Marcel Dekker 405-419, 1998
1 McCay PB., "Vitamin E: interactions with free radicals and ascorbate" 5 : 323-340, 1985
2 Jang AS, "The relationship between alveolar epithelial proliferation and airway obstruction after ozone exposure" 57 : 737-740, 2002
3 문희범, "The Role of Oxidative Stress in the Pathogenesis of Asthma" 대한천식알레르기학회 2 (2): 183-187, 2010
4 De Azevedo WF Jr, "Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase" 93 : 2735-2740, 1996
5 Saliou C, "Solar ultravioletinduced erythema in human skin and nuclear factorkappa- B-dependent gene expression in keratinocytes are modulated by a French maritime pine bark extract" 30 : 154-160, 2001
6 Finkel T., "Signal transduction by reactive oxygen species" 194 : 7-15, 2011
7 Morabia A, "Serum retinol and airway obstruction" 132 : 77-82, 1990
8 Boege F, "Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase" 271 : 2262-2270, 1996
9 Comhair SA, "Redox control of asthma: molecular mechanisms and therapeutic opportunities" 12 : 93-124, 2010
10 Rohdewald P., "Pycnogenol, In Flavonoids in Health and Disease" Marcel Dekker 405-419, 1998
11 Rong Y, "Pycnogenol protects vascular endothelial cells from t-butyl hydroperoxide induced oxidant injury" 5 : 117-126, 1994
12 Heffner JE, "Pulmonary strategies of antioxidant defense" 140 : 531-554, 1989
13 Jang AS, "Prolonged ozone exposure in an allergic airway disease model: adaptation of airway responsiveness and airway remodeling" 7 : 24-, 2006
14 Virgili F, "Procyanidins extracted from Pinus maritima (Pycnogenol): scavengers of free radical species and modulators of nitrogen monoxide metabolism in activated murine RAW 264.7 macrophages" 24 : 1120-1129, 1998
15 Ueda T, "Preventive effect of natural and synthetic antioxidants on lipid peroxidation in the mammalian eye" 28 : 184-192, 1996
16 Masquelier J, "Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenging effect and use thereof"
17 Leikauf GD, "Ozonolysis products of membrane fatty acids activate eicosanoid metabolism in human airway epithelial cells" 9 : 594-602, 1993
18 Blomberg A, "Ozoneinduced lung function decrements do not correlate with early airway inf lammatory or antioxidant responses" 13 : 1418-1428, 1999
19 Gordon T, "Ozone inhibition of tissue cholinesterase in guinea pigs" 36 : 284-288, 1981
20 Wiester MJ, "Ozone adaptation in mice and its association with ascorbic acid in the lung" 12 : 577-590, 2000
21 Kliment CR, "Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis" 49 : 707-717, 2010
22 Bast A, "Oxidative stress and antioxidants in interstitial lung disease" 16 : 516-520, 2010
23 Macnee W, "Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease" 160 (160): 58-65, 1999
24 Nadeem A, "Oxidant: antioxidant imbalance in asthma: scientific evidence, epidemiological data and possible therapeutic options" 2 : 215-235, 2008
25 Greenberg SS, "Nitro containing L-arginine analogs interfere with assays for nitrate and nitrite" 57 : 1949-1961, 1995
26 Jang AS, "Neuronal nitric oxide synthase is associated with airway obstruction in BALB/c mice exposed to ozone" 70 : 95-99, 2003
27 Balaban RS, "Mitochondria, oxidants, and aging" 120 : 483-495, 2005
28 Kafoury RM, "Lipid ozonation products activate phospholipases A2, C, and D" 150 : 338-349, 1998
29 Kafoury RM, "Induction of inflammatory mediators in human airway epithelial cells by lipid ozonation products" 160 : 1934-1942, 1999
30 Holtzman MJ, "Importance of airway inflammation for hyperresponsiveness induced by ozone" 127 : 686-690, 1983
31 Mikerov AN, "Impact of ozone exposure on the phagocytic activity of human surfactant protein A (SP-A) and SP-A variants" 294 : 121-130, 2008
32 Park HS, "Impact of oxidative stress on lung diseases" 14 : 27-38, 2009
33 Cheshier JE, "Immunomodulation by pycnogenol in retrovirus-infected or ethanol-fed mice" 58 : 87-96, 1996
34 Committee of the Environmental and Occupational Health Assembly of the American Thoracic Society, "Health effects of outdoor air pollution" 153 : 3-50, 1996
35 Burton GW, "First proof that vitamin E is major lipid-soluble, chain-breaking antioxidant in human blood plasma" 2 : 327-, 1982
36 Jang AS, "Epidemiologic evidence of a relationship between airway hyperresponsiveness and exposure to polluted air" 58 : 585-588, 2003
37 Moini H, "Enzyme inhibition and protein-binding action of the procyanidin-rich french maritime pine bark extract, pycnogenol: effect on xanthine oxidase" 48 : 5630-5639, 2000
38 van Jaarsveld H, "Effect of flavonoids on the outcome of myocardial mitochondrial ischemia/reperfusion injury" 91 : 65-75, 1996
39 Shahar E, "Does dietary vitamin A protect against airway obstruction? The Atherosclerosis Risk in Communities (ARIC) Study Investigators" 150 : 978-982, 1994
40 Koley AP, "Differential mechanisms of cytochrome P450 inhibition and activation by alpha-naphthof lavone" 272 : 3149-3152, 1997
41 Mudway IS, "Differential depletion of human respiratory tract antioxidants in response to ozone challenge" 25 : 499-513, 1996
42 Kari F, "Dietary restriction mitigates ozone-induced lung inflammation in rats: a role for endogenous antioxidants" 17 : 740-747, 1997
43 Bieri JG, "Determination of alpha-tocopherol in erythrocytes by gas-liquid chromatography" 11 : 118-123, 1970
44 Jang AS, "Changes in the expression of NO synthase isoforms after ozone: the effects of allergen exposure" 5 : 5-, 2004
45 Ohkawa H, "Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction" 95 : 351-358, 1979
46 Freed AN, "Antioxidant transport modulates peripheral airway reactivity and inflammation during ozone exposure" 87 : 1595-1603, 1999
47 Romieu I, "Antioxidant supplementation and respiratory functions among workers exposed to high levels of ozone" 158 : 226-232, 1998
48 Jang AS, "Antioxidant responsiveness in BALB/c mice exposed to ozone" 72 : 79-84, 2005
49 Kelly FJ, "Antioxidant kinetics in lung lavage fluid following exposure of humans to nitrogen dioxide" 154 (154): 1700-1705, 1996
50 Wood LG, "Antioxidant and antiinf lammatory effects of resveratrol in airway disease" 13 : 1535-1548, 2010
51 Packer L, "Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol" 27 : 704-724, 1999
52 Rice-Evans CA, "Antioxidant activities of flavonoids as bioactive components of food" 24 : 790-795, 1996
53 Blazso G, "Antiinflammatory and superoxide radical scavenging activities of procyanidins containing extract from the bark of Pinus pinaster Sol. and its fractions" 3 : 217-220, 1994
54 Jang AS, "Airway obstruction after acute ozone exposure in BALB/ c mice using barometric plethysmography" 18 : 1-5, 2003
55 Jacky JP, "A plethysmograph for long-term measurements of ventilation in unrestrained animals" 45 : 644-647, 1978